Photo of Dr Misha Kabir

Dr Misha Kabir

Email:

Location:

  • University College Hospital

GMC/GDC number:

6159441

Professional background

Dr Misha Kabir is a consultant gastroenterologist with a specialist interest in inflammatory bowel disease. She completed her undergraduate medical training at the University of Cambridge and King’s College London before qualifying in 2007. Her postgraduate gastroenterology training in London included a research and teaching fellowship at St Mark’s Academic Institute. She was awarded a PhD on optimising the risk stratification and management of colitis-associated dysplasia by Imperial College London. Her ongoing clinical and research interests are focused on inflammatory bowel disease therapeutics, colonoscopic surveillance and cancer prevention. Her research has led to several first-author publications in high-impact peer-reviewed journals.

She remains committed to clinical research and improving the standards of clinical care. She is a principal investigator and contributor to commercial and investigator-led clinical studies at UCLH. She has a keen interest in undergraduate/postgraduate teaching and has a postgraduate qualification in medical education. She is experienced in undertaking and teaching endoscopy and has a specialist interest in IBD surveillance colonoscopy. She plays an active role within the British Society of Gastroenterology and has been an advocate for equality, diversity and inclusion in her former role as Chair of the Supporting Women in Gastroenterology (SWiG) committee. She is a co-author of the 2024 updated British Society of Gastroenterology guidelines for IBD management and for IBD colorectal cancer surveillance.

Specialties

Research interests

  • Inflammatory bowel disease
  • Colitis-associated neoplasia prevention and colonoscopic surveillance
  • Patient experience optimisation and shared decision-making

Publications

An up to date list of Misha’s publications is available via these links: https://orcid.org/0000-0003-3991-1015 or www.researchgate.net/profile/Misha-Kabir

  • East JE, Kabir M. Preventing Post-colonoscopy Colorectal Cancer in Inflammatory Bowel Disease – “The Big Five”. Journal of Crohn’s and Colitis. September 2024; https://doi.org/10.1093/ecco-jcc/jjae140
  • Kabir M, et al. Cancer Biology or Ineffective Surveillance? A multicentre retrospective analysis of colitis-associated post-colonoscopy colorectal cancers. Journal of Crohn’s and Colitis. Nov 2023. jjad189. doi: 10.1093/ecco-jcc/jjad189. Epub ahead of print. PMID: 37941424.
  • Kabir M, Thomas-Gibson S, et al. DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making. Journal of Crohn’s and Colitis. Nov 2023; 17(10):1652-1671. doi: 10.1093/ecco-jcc/jjad083. PMID: 37171140.
  • Al Bakir I, Kabir M, Yalchin M, Hart A. Optimising inflammatory bowel disease surveillance and dysplasia management – Where do we stand? United European Gastroenterol J. Dec 2022; 10(10):1054-1062. doi: 10.1002/ueg2.12330. PMID: 36349435; PMCID: PMC9752268.
  • Kabir M, Matharoo M, Dhar A, et al. BSG Survey on Impact of COVID-19 Recovery on Workforce, Workload and Wellbeing. Frontline Gastroenterology. Nov 2022; 4(3):236-243. doi: 10.1136/flgastro-2022-102298. PMID: 37056317; PMCID: PMC10086704.
  • King J, Poo SX, El-Sayed A, Kabir M, et al. Towards NHS Zero: Greener Gastroenterology. The impact of virtual clinics on carbon emissions and patient outcomes - a multi-site, observational, cross-sectional study. Frontline Gastroenterology. Nov 2022; 14(4):287-294. doi: 10.1136/flgastro-2022-102215. PMID: 37409339.
  • Neyazi N, Safi N, Afzali A, Kabir M. Gender barriers are worsening women’s access to healthcare in Afghanistan. The Lancet. September 2022; 400(10354); p731-732
  • Curtius K, Kabir M (joint first author), Al Bakir I, Choi C-HR, Hartono J, Johnson M, East JE, Lindsay JO, Vega R, Warusavitarne J, Thomas-Gibson S, Wilson A, Graham TA, Hart AL. Multi-centre derivation and validation of a colitis-associated colorectal cancer risk prediction web-tool. Gut. April 2022; 71(4):705-715.doi: 10.1136/gutjnl-2020-323546.
  • Ahmad A, Dhillon A, Saunders BP, Kabir M, Thomas-Gibson S. Validation of post-colonoscopy colorectal cancer (PCCRC) cases reported at national level following local root cause analysis: REFLECT study. Frontline Gastroenterology. January 2022; 13(5):374-380. doi: 10.1136/flgastro-2021-102016.
  • Kabir M, Thomas-Gibson S, Hart AL, Wilson A. Perception of cancer risk and management practice for colitis-associated dysplasia is influenced by colonoscopy experience and workplace results of an interna- tional clinician survey. Journal of Crohn’s and Colitis. June 2021; 16(1):39-48. doi: 10.1093/ecco-jcc/jjab110.
  • Kabir M, Thomas-Gibson S, Hart AL, Tozer PJ, Warusavitarne J, Faiz O, Wilson A. Management of in- flammatory bowel disease-associated colonic dysplasia: factors predictive of patient choice and satisfac- tion. Colorectal Disease. April 2021; 23(4):882-893. DOI: 10.1111/codi.15460
  • Kabir M, Shakweh E, Segal J. Fostering mentorship and collaboration: how to set up a trainee research network. Royal College of Physicians Commentary magazine. September 2020.
  • Kabir M, Fofaria R, Arebi N, Bassett P, Tozer PJ, Hart AL, Thomas-Gibson S, Humphries A, Suzuki N, Saunders B, Warusavitarne J, Faiz O, Wilson A. Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present). Alimentary Pharmacology and Therapeutics. July 2020; 52:5-9. DOI: 10.1111/apt.15778
  • Kabir M. Does artificial intelligence (AI) constitute an opportunity or a threat to the future of medicine as we know it? Future Healthcare Journal. Oct 2019; 6(3):190-191. doi: 10.7861/fhj.teale-6-3.
  • Kabir M. (2019) ‘Change in Bowel Habit’, in Chen, Y., Pitcher, M. and Camm, CF. (eds.) A Clinical Guide to Gastroenterology. Wiley-Blackwell, pp. 85 – 98. ISBN: 978-1-119-18916-9
  • Kabir M. (2019) ‘Weight Loss, in Chen, Y., Pitcher, M. and Camm, CF. (eds.) A Clinical Guide to Gastroenterology. Wiley-Blackwell. ISBN: 978-1-119-18916-9
  • Samaan MA, Forsyth K, Segal JP, de Jong D, Vleugels J, Elkady S, Kabir M, et al. Current Practices in Ileal Pouch Surveillance for Patients with Ulcerative Colitis: A Multinational, Retrospective Cohort Study. Journal of Crohns and Colitis. May 2018; 13(6):735-743. doi: 10.1093/ecco-jcc/jjy225. PMID: 30590513.
  • Mullish BH, Kabir M (joint first author), Thursz MR, Dhar A. Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther. Oct 2014; 40(8):880-92. PMID: 2517590